WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
China's Xi Jinping delivers unexpected speech at UN hours after US President Joe Biden speaksWas the Budget too little, too lateNASA is looking for new astronauts'Sorry, you can't board, off you pop': Traveller reveals how he was caught out by a postMercedes upgrades its electric EQS to give the EV a huge 511 mileInside Thailand's last untouched island: Empty beaches, authentic villages, mangrove forestsMy widowed 77Will the highI took a flight from Bristol to Edinburgh instead of getting the trainWorld's biggest bridges revealed after collapse of colossal Baltimore landmark